Kathryn has 20 years of program management experience in the biotech/pharma industry. Her PM leadership spans preclinical to post approval life cycle management. Prior to RayzeBio, Kathryn led programs at Ultragenyx, AbbVie and Abbott. She holds an MBA from HEC, Paris and a BS in Chemistry from Virginia Tech.